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a b s t r a c t 
Oxaliplatin is the newest platinum-based drug to be used widely in chemotherapy. However, very little is known 
about its behaviour and toxicity once discharged to the environment. In this study, the freshwater macrophyte, 
Lemna minor , has been exposed to three concentrations of the drug (low, medium and high; 0.4, 10 and 100 𝜇g 
mL − 1 , respectively) for seven days according to OECD guidelines and the growth rate, biochemical changes and 
extent of membrane damage determined. The stability of oxaliplatin was also monitored during the exposures and 
the accumulation, as both adsorbed and internalised fractions, evaluated by chemical extraction and digestion 
at the end of the experiment. Oxaliplatin appeared to remain intact throughout, with no measurable metabolite 
formation in the growth medium, and bioconcentration factors were < 100 mL g − 1 . The majority of oxaliplatin 
taken up by L. minor (about 66 to 84%) was internalised, presumably through passive diffusion and, possibly, 
uptake through transporters. Among the end-points tested, only relative growth rate of frond area and ion leakage 
were adversely affected at the medium and/or high concentrations employed. These observations suggest that 
oxaliplatin is unlikely to be phytotoxic at concentrations typically encountered in the environment and that L. 















































Over the past two decades, the presence and impacts of pharmaceu-
icals in the environment have gained increasing attention ( Besse and
arric, 2008 ; Laurenson et al., 2014 ; Ojemaye and Petrik, 2019 ). Human
nd veterinary pharmaceuticals and their metabolites enter the aquatic
nvironment largely through treated and untreated hospital and munic-
pal waste waters ( Souza and Feris, 2016 ; Ting and Praveena, 2017 ),
lthough effluents from manufacturing plants may also act as localised
ources ( Cardoso et al., 2014 ). Despite resulting concentrations that are
ow compared with many other contaminants like metals, nutrients, hy-
rocarbons and microplastics, the functions and mechanisms of action of
harmaceuticals raise concerns about their chronic effects on non-target
rganisms ( Fent et al., 2006 ; Walker and McEldowney, 2013 ). 
Cytostatic drugs are a group of antineoplastic agents that are widely
sed to treat cancer by inhibiting the replication of DNA and interven-
ng in cell division. Their mode of action also ensures that they are
oxic to non-cancerous cells, however, suggesting that all eukaryotic or-
anisms could be at risk from environmental exposure ( Johnson et al.,
008 ). Platinum-based coordination complexes are an important and
ommonly employed group of alkylating cytostatic drugs that may be∗ Corresponding author. 
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 http://creativecommons.org/licenses/by-nc-nd/4.0/ ) sed either as a single therapeutic modality or in combination with
ther agents or with radiotherapy ( Wang and Guo, 2013 ). The principal
hemicals in this group are cisplatin ( cis -dichlorodiamineplatinum(II)),
arboplatin ( cis -diammine(1,1-cyclobutanedicarboxylato)platinum(II))
nd oxaliplatin (( cis -[1 R ,2 R ]-1,2-cyclohexanediamine- N,N ′ )oxalato(2-)-
,O ′ platinum(II)). Oxaliplatin, whose structure is shown in Fig. 1 , is the
ewest platinum-based derivative to be internationally approved and
sed in standard chemotherapy and was developed as a less toxic and
ore effective alternative to cisplatin. Oxaliplatin is used to treat vari-
us solid tumours but most commonly colorectal cancer and is usually
dministered with fluorouracil and leucovorin as synergists ( Kwok et al.,
017 ). The molecule is characterised by an oxalate (ox) leaving group
nd a diaminocyclohexane (dach) carrier ligand, and may be thus ab-
reviated as: [Pt(dach)(ox)] ( Alcindor and Beauger, 2011 ). While the
ompound itself is highly soluble and appears to be pharmacologi-
ally inactive, in plasma the oxalate group is displaced and reactive
ichloro (dach) complexes, [Pt(dach)Cl 2 ], enter the cell as cytotoxins
 Jerremalm et al., 2009 ). 
Despite the common and increasing usage of platinum-based cyto-
tatic drugs, very little information exists on their environmental be-
aviour and toxicity, and with most of the focus to date on cisplatinanuary 2021 
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Fig. 1. The structure of oxaliplatin (( cis -[1 R ,2 R ]-1,2-cyclohexanediamine- 







































































































t   Supalkova et al., 2008 ; Curtis et al., 2010 ; Easton et al., 2011 ;
rezov š ek et al., 2014 ; Fonseca et al., 2017 ). For oxaliplatin, the ad-
orption to sediment and soil has been investigated under controlled
onditions ( Turner and Mascorda, 2015 ; Goykhman et al., 2018 ) but in-
ormation on its interaction with and toxicity to biota appears to be lim-
ted to a single recent study using Chlorella vulgaris ( Dehghanpour et al.,
020 ). Here, it was found to be the least toxic among the three main
latinum-based cytotoxic drugs to the microalga according to various
nd-points. 
In the present study, we examine the uptake of oxaliplatin by and its
ffects on the duckweed, Lemna minor , a limnic vascular plant. L. minor
s commonly encountered in temperate freshwaters and is an important
ood source and habitat for a range of organisms. The macrophyte is
asily cultured and handled and is also often employed in ecotoxico-
ogical studies as a representative of higher aquatic plants according to
ECD and ISO test guidelines ( Drost et al., 2007 ). Specifically, we study
he adsorbed-internalised distribution of oxaliplatin in L. minor and the
ffects of the drug on frond growth and on physiological and biochem-
cal changes to fronds. In addition to providing valuable information
n uptake and toxicity, the study also allows us to assess the potential
or L. minor to act as a biomonitor or phytoremediater in contaminated
aters. 
. Materials and methods 
.1. Materials 
All plastic-ware and glassware used for culturing and in the experi-
ents were soaked in 0.5% general purpose sodium hypochlorite solu-
ion, an antineoplastic inactivator and decontaminant ( Benvenuto et al.,
993 ), and subsequently rinsed with Millipore Milli-Q water (MQW).
ork involving the preparation and handling of oxaliplatin was per-
ormed on a Chemoprotect cytostatic mat in a Bigneat biological class
I safety cabinet while wearing appropriate protective gear. 
.2. Cultivation of Lemna minor 
A known and established Lemna minor strain (UTCC# 490) was used
hroughout this study . Stock material was cultured and maintained ac-
ording to OECD 221, Lemna sp . growth inhibition test ( OECD, 2006 ),
n transparent plastic tanks (35 cm × 70 cm) filled with Swedish Insti-
ute standard growth medium (SIS) in a greenhouse. When required for
xperimentation, plants were transferred to the laboratory and washed
ith tap water several times to remove any adhering debris before be-
ng surface-sterilised by soaking in 0.5% v/v ethanol (Fisher Scientific
PLC grade) for 30 s, immersing in a solution of 0.5% v/v NaOCl (Fisher
cientific HPLC grade) for 3 min and rinsing with MQW for 15 min
 Wang et al. 2012 ). Plants were then allowed to multiply and acclimate
or four weeks in sterilised 100 mm x 20 mm polystyrene petri dishes2 ontaining 80 mL of sterile (autoclaved) SIS medium at pH 6.5 ± 0.5 in a
anyo controlled environment chamber. Temperature was set at 24°C
nd fluorescent light (OSRAM TL- Tube D36W/Brite Gro 2048, Ger-
any) of intensity 35 μmol m − 2 s − 1 was employed for a photoperiod of
4 h light per day. In order to minimise contamination, plants were sub-
ultured once per week ( OECD 2006 ). During this process, phosphate-
uffered saline (NaCl) solution (ACS reagents, Sigma-Aldrich) at pH 6.4
as used as an isotonic and non-toxic rinse. 
.3. Experimental procedure 
Experiments were performed in triplicate and under the conditions
escribed above for a period of 7 d in 6-well plates with covers contain-
ng 10 mL of oxaliplatin-amended SIS and about 100 mg of biomass per
ell, or in loosely-lidded 100 mL clear polyethylene beakers containing
0 mL of oxaliplatin-amended SIS and about 500 mg biomass per ves-
el. The concentrations of oxaliplatin, prepared from a stock infusion
olution of 5 mg mL − 1 (Accord Healthcare Ltd, batch PP02066) and di-
utions thereof in SIS medium, were 0 (control), 0.4 𝜇g mL − 1 (1 𝜇M;
ow), 10 𝜇g mL − 1 (25 𝜇M; medium) and 100 𝜇g mL − 1 (250 𝜇M; high). 
After the acclimation period, a weighed quantity (with the precise
mount dependent on the end-point investigated) of light-green, healthy
iomass was transferred to each reaction vessel with the aid of a dispos-
ble plastic inoculation loop. 
.3.1. End-points (growth analyses) 
To determine relative growth rate based on mass (RGR FW ; g g 
− 1 d − 1 ),
resh biomass (FW; g) was determined on an analytical balance at the
eginning, t 0 , and end, t e , of each 7-d exposure after plants had been
lotted with absorbent paper: 
G R FW = 
(




𝑡 𝑒 − 𝑡 0 
)
(1) 
Total frond area (TFA; mm 2 ) was measured at the beginning and
nd of each exposure using a scanning plant meter (Delta-T devices,
ambridge) and relative growth rate based on total frond surface area
RGR TFA ; mm 
2 mm − 2 d − 1 ) was calculated as follows: 
G R TFA = 
(




𝑡 𝑒 − 𝑡 0 
)
(2) 
.3.2. End-points (physiological analyses) 
The percentage leakage of cellular ions as a measure of mem-
rane damage was determined following the protocol of Devi and
rasad (1998) with some modifications. Thus, at the termination of the
xperiment, approximately 30 mg of fronds from each replicate were
mmersed in 10 mL of MQW in 15 mL plastic centrifuge tubes. The ini-
ial conductivity of the medium, C 1 , was measured using a temperature
ompensated conductivity meter (CMD8500/Walden Precision Appara-
us Ltd). Tubes were subsequently placed in a Techne Dri DB-2TC heat-
ng block at 80°C for 15 min and cooled over ice with the final conduc-
ivity, C 2 , measured as above. Percentage ion leakage was derived from
 1 /( C 1 + C 2 ). 
.3.3. End-points (biochemical analyses) 
Lipid peroxidation is one of the biochemical changes as a symptom
f oxidative stress in plants by production of reactive oxygen species
 Sharma et al. 2012 ). The level of lipid peroxidation products can be
xpressed as 2-thiobartbituric acid (TBA) and was determined after the
xposure period by estimation of the relative malondialdehyde (MDA)
ontent following Heath and Packer (1968) with slight modification. 
Biomass arising from the exposures which had been stored frozen
n a New Brunswick Scientific Ultra low temperature freezer at -80°C
as homogenized vigorously in a ceramic pestle and mortar with 10%
w/v) trichloroacetic acid (TCA; Fisher Scientific HPLC grade) in a ratio
f 100 mg of tissue to 1 mL of TCA. Material was then kept on ice be-
ore centrifuging at 10,000 g for 5 min at 4°C in 2.5 ml plastic centrifuge
ubes. Supernatants were treated with an equal volume of 0.25% (w/v)































































Concentrations (square brackets) and distributions (as K D and BCF) 
of Pt arising from 7-d exposure of different quantities of oxaliplatin 
to L. minor . Abbreviations are explained in the accompanying text 
and errors represent the standard deviation about the mean of three 
independent experimental measurements. 
exposure low medium high 
[OP]-added, 𝜇g mL –1 0.4 10 100 
[Pt]-added, 𝜇g mL –1 0.2 4.91 49.1 
[Pt] aq , 𝜇g mL 
–1 0.20 ± 0.07 4.27 ± 0.16 34. 6 ± 0.52 
[Pt] ext , 𝜇g g 
–1 1.60 ± 0.21 32.5 ± 1.65 506.0 ± 74.2 
[Pt] tot , 𝜇g g 
–1 5.06 ± 1.99 138.2 ± 34.5 3253 ± 645. 1 
[Pt] int , 𝜇g g 
–1 3.46 ± 1.83 120.1 ± 32.2 2747 ± 572 
[Pt] int /[Pt] tot , % 66.0 ± 10.2 78.3 ± 3.73 84.3 ± 0.98 
K D , mL g 
–1 8.74 ± 3.56 7.59 ± 0.77 14.6 ± 2.11 












































[  BA and incubated in a heating block at 95°C for 30 min after tube
ids had been pierced with a needle before the contents were rapidly
ooled on ice. The absorbance of the TBA-MDA complexes in the super-
atants was read at 532 nm and corrected for non-specific turbidity by
ubtracting absorbance at 600 nm using a UNICAM Spectrophotometer.
DA concentration was determined on a fresh weight basis using 155
M − 1 cm − 1 as an extinction coefficient. 
.3.4. Qualitative observations 
Changes in plant appearance, including chlorosis, necrosis, frond
ize, frond disconnection and gibbosity, were checked and recorded at
he beginning and the end of the exposures. 
.4. Oxaliplatin measurements 
The stability of oxaliplatin under the exposure conditions was eval-
ated for a period of 7 d in a series of separate experiments in which
.4, 10 or 100 𝜇g mL − 1 of the chemical was added to HPLC-grade water
nd to SIS medium with L. minor . Thus, at selected times, triplicate 1 mL
liquots were pipetted into 2 mL HPLC vials, and 20 𝜇L were injected
nto the HPLC column (Water Spherisorb 4.6 mm x 250 mm stainless
teel packed with 5.0 𝜇m bonded phase cyano CNRP; Waters Ltd). The
olumn was operated at a flow rate of 1.2 mL min − 1 , a run time of 10
in and a temperature of 35°C, and separation was achieved under iso-
ratic conditions with a mobile phase of 5 mM phosphate buffer and 1%
ropan-2-ol (Fisher Scientific HPLC grade) at pH 6.5. A UV diode-array
etector at 200-210 nm was employed and Jasco ChromPass version
.8.6.1 was used to analyse chromatographic data. 
The HPLC assay described was validated over the duration of the
tability study with acceptance criteria adopted from British Pharma-
opoeia and European Pharmacopoeia. Thus, intra-day precision and
nter-day precision were validated by the analysis of six, freshly pre-
ared 20 𝜇g mL − 1 solutions of oxaliplatin in HPLC-grade water on a
aily basis (and over a period of 7 d) with acceptance criteria of < 2%
as relative standard deviation). Linearity was validated from a plot of
ean peak height arising from three replicate injections for oxaliplatin
oncentrations in the range 1.0 to 90 𝜇g mL − 1 and a least-squares fitted
egression coefficient of > 0.99. 
.5. Platinum concentrations 
At the end of an independent series of exposures, concentrations of
latinum (Pt) were determined in the growth medium, in L. minor , and
dsorbed to the container. Thus, 1 mL aliquots of the growth medium
ere pipetted into screw-capped 15 ml plastic tubes and acidified with
 mL of 2% HNO 3 (Fisher Scientific Trace Metal Grade). Solutions were
nalysed for Pt by inductively coupled plasma-optical emission spec-
roscopy (ICP-OES; Thermo Scientific ICAP 7400). The instrument was
alibrated with standards prepared from a 10,000 mg L − 1 solution that
ad been diluted in acidified SIS medium and was operated under con-
itions described elsewhere ( Bull et al., 2017 ). Platinum was analysed
t 214.423 nm and 217.467 nm, with both wavelengths returning very
imilar results and indicating that spectral interferences were unlikely.
mptied vessels were subsequently washed with SIS medium before be-
ng rinsed with 50 mL of 0.1 M HNO 3 for 15 min. Rinses were anal-
sed for 195 Pt by inductively coupled plasma-mass spectroscopy (ICP-
S; ThermoScientific iCAP RQ ICP-MS) under operating conditions de-
cribed elsewhere ( James and Turner, 2020 ). 
Portions of about 250 mg of fresh biomass were washed three times
n MQW and blotted dry before being frozen at -80 °C and freeze-dried in
n Edwards Super Modulyo freeze-drier. Dried and re-weighed samples
ere then added to 10 mL of 3 mM of ethylene diamine tetra-acetic
cid (EDTA; ACS reagent, Sigma-Aldrich) for approximately 20-25 min
n a series of 15 mL polypropylene centrifuge tubes to release adsorbed
extracellular) metal ( Hassler et al., 2004 ). Meanwhile, separate 250
g portions biomass were dried overnight in a Gollenkamp incubator3 t 72°C before being re-weighed and completely digested in 10 mL of
6 M HNO 3 in 60 mL centrifuge tubes in a water bath at 85°C for 48
. MQW-diluted digests and EDTA extracts were analysed by ICP-MS as
bove. 
Aqueous and biomass concentrations of OP in the exposures are pre-
ented in terms of Pt after correction for any metal returned in the cor-
esponding controls, and concentrations of Pt accumulated by L. minor
re given on a dry weight basis after correction for the water content
f biomass. Intracellular Pt concentrations were derived by subtract-
ng extracellular (EDTA-extractable) concentrations from total (acid di-
estible) concentrations. 
. Results 
.1. Oxaliplatin stability 
Fig. 2 shows the mean measured concertation of oxaliplatin, [OP] aq ,
s a function of time after being added at three different concentrations
low, medium and high) to HPLC-grade water and to SIS medium in the
resence of L. minor . Compared with the original concentration, there is
o clear reduction over the time-course for any oxaliplatin concentration
mployed or in either pure water or the growth medium, and additional
eaks in the region of the oxaliplatin peak were never observed on the
hromatograms. 
.2. Concentrations and partitioning of Pt 
Table 1 shows the concentrations and distributions (partitioning) of
t, as a measure of oxaliplatin and as determined by ICP, at the end
f a series of exposures. Note that adsorption of Pt to the interior sur-
aces of the polyethylene beakers was < 0.3% of the quantity added in
ach exposure suggesting that chemical artefacts arising from sample
ontainment are minimal. Thus, [OP]-added is the concentration of ox-
liplatin added to each exposure, [Pt]-added represents the equivalent
oncentration of Pt added at the beginning of the experiment (and where
Pt] = 0.491 ∗ [OP]) and [Pt] aq is the concentration of Pt remaining in
he aqueous phase after 7 d; [Pt] ext and [Pt] tot are the extracellular and
otal concentrations of Pt in L. minor after 7 d, respectively, determined
y EDTA extraction and HNO 3 digestion, respectively, and converted
o a dry weight basis, and [Pt] int is the internalised concentration, de-
ived from the difference between [Pt] tot and [Pt] ext . Also shown are
he percentage of Pt accumulated by L. minor that is internalised ( =
Pt] int /[Pt] tot 
∗ 100%), the bioconcentration factor, BCF (mL g − 1 ), defin-
ng the concentration of Pt in the organism relative to the concentra-
ion in the surrounding aqueous medium at the end of the exposure ( =
Pt] tot /[Pt] aq ), and an adsorption constant, K D (mL g 
− 1 ), that defines
he concentration of Pt adsorbed to the surface of the plant relative to
he concentration in the aqueous medium at the end of the exposure ( =
Pt] ext /[Pt] aq ). Results reveal that the majority of Pt accumulated by L.
V. Kajander, G. Sewell and A. Turner Environmental Advances 3 (2021) 100030 
Fig. 2. Mean concentrations of aqueous oxali- 
platin, [OP] aq , in conditions replicating the ex- 
posures: 0.4 OP = 0.4 𝜇g mL − 1 oxaliplatin in 
HPLC-grade water; 10 OP = 10 𝜇g mL − 1 ox- 
aliplatin in HPLC-grade water; 100 OP = 100 
𝜇g mL − 1 oxaliplatin in HPLC-grade water; 
0.4 OP + Lm = 0.4 𝜇g mL − 1 oxaliplatin in 
SIS medium in the presence of L. minor ; 10 
OP + Lm = 10 𝜇g mL − 1 oxaliplatin in SIS 
medium in the presence of L. minor ; 100 
OP + Lm = 100 𝜇g mL − 1 oxaliplatin in SIS 
medium in the presence of L. minor. Note that 
errors are not shown but were smaller than the 
size of the symbols (relative standard devia- 
tions < 3%; n = 3). 
Fig. 3. Visual appearance of L. minor in 60 
mL beakers and exposed to different concen- 
trations of oxaliplatin: (a) 0 𝜇g mL − 1 , (b) 0.4 


































e  inor at all added oxaliplatin concentrations is internalised and that the
CF increases with increasing added concentration of the drug. 
.3. Visual and quantitative end-points 
In the control exposures, plants were healthy and green, with a few
ndividuals displaying loss of colour (yellow or white). Increasing con-
entrations of oxaliplatin were accompanied by increasing loss of frond
olour or an increasing number of fronds that were discoloured (see
ig. 3 ), and at the high concentration there was some detachment of
ronds from roots. 
Quantitative end-points arising from the growth, physiological and
iochemical analyses of 7-d exposures are shown in Fig. 4 . Indicated in
ach case are significant differences ( p < 0.05) from the control accord-
ng to one-way analysis of variance and after confirmation for normal-
ty (Shapiro-Wilk test) and equal variance (Brown-Forsythe test). Thus,
here is a significant reduction in growth rate based on frond area at
he highest concentration of oxaliplatin employed, and a significant in-
rease in ion leakage at added concentrations of 10 and 100 𝜇g mL − 1 .4 owever, exposure to oxaliplatin results in no statistical differences in
rowth rate based on biomass and MDA content as a measure of lipid
eroxidation relative to the corresponding controls. 
. Discussion 
A critical characteristic of Pt-based drugs in experiments of the na-
ure described here is their propensity to degrade or transform in aque-
us solutions, as they are designed to do from a pharmacological per-
pective. The most abundant nucleophile in the SIS medium is chlo-
ide (~ 0.5 mM), with the oxaliplatin concentrations employed in our
xposures yielding a [Cl − ]:[oxaliplatin] molar ratio of between 2 and
00. Previous studies have reported the formation of [Pt(dach)(ox)Cl] − ,
Pt(dach)Cl 2 ] and [Pt(dach)Cl(OH 2 )] 
+ in aqueous solutions within a
ew hours at [Cl − ]:[oxaliplatin] ratios similar to the maximum val-
es used here ( Jerremalm et al., 2009 ; Mehta et al., 2015 ). However,
hese studies were undertaken at significantly higher temperatures (37
o 42°C). No clear difference in chromatographic peak heights between
qual oxaliplatin concentrations in pure water, in which Cl − is absent,
V. Kajander, G. Sewell and A. Turner Environmental Advances 3 (2021) 100030 
Fig. 4. Relative growth rates (a and b), ion 
leakage (c) and malondialdehyde content (d) 
after 7-d exposure to different added concen- 
trations of oxaliplatin ([OP]-added). Errors rep- 
resent standard deviation about the mean of 
three independent measurements and asterisks 
denote a significant difference from the corre- 










































































t  nd the SIS medium containing L. minor , coupled with no reduction in
eak height over the time course of the experiment suggest that oxali-
latin itself, [Pt(dach)(ox)], may be stable under the experimental con-
itions employed here. However, because some species may not have
een detected by the UV detection system in the HPLC assay ( Liu, 2016 ),
hen we refer to oxaliplatin in the discussion below we acknowledge
hat small but significant contributions from unidentified chloro-based
r aquated transformation products may well have evolved during the
xposures. 
The BCF defines the bioaccumulation of a contaminant by a plant
and here by the roots and fronds) relative to the amount in ambient wa-
er and for oxaliplatin is low compared with other metallic contaminants
tudied under similar conditions and timeframes. For example, while
CFs for oxaliplatin are < 100 mL g − 1 ( Table 1 ), heavy metal ions (in-
luding oxyanions) typically exhibit values on the order of thousands to
ens of thousands of mL g − 1 for L. minor ( Weltje et al., 2002 ; Uysal, 2013 ;
lement and Lamonica, 2018 ). The relatively low accumulation and ad-
orption of oxaliplatin by the duckweed is consistent with the high sol-
bility and hydrophilicity of the molecule (solubility = 7.9 g L − 1 and
og K ow = -0.05; Vyas et al., 2014 ) and its rather low reactivity towards
iochemicals and geosolids (sand, soil and sediment) compared with its
harged metabolites like [Pt(dach)(OH 2 ) 2 ] 
2 + and [Pt(dach)Cl(OH 2 )] 
+ 
Verstraete et al., 2001; Alcindor and Beauger, 2011 ; Turner and Mas-
orda, 2015 ; Goykhman et al., 2018 ). Because of the small size and lack
f charge of the oxaliplatin molecule, adsorption is likely to involve
on-specific molecular interactions with biomolecules like membrane
roteins and lipids at the plant surface and internalisation is predicted
o be passive. However, recent empirical evidence suggests that active
ncorporation of Pt drugs, including oxaliplatin, into cells may also take
lace through certain transport systems (e.g. copper influx and efflux
ransporters) ( Martinez-Balibrea et al., 2015 ; Martinho et al., 2019 ). De-
pite uncertainties in the mechanisms of interaction, L. minor is not pre-
icted to be particularly useful for the biomonitoring or bioremediation
f water contaminated by oxaliplatin (e.g. hospital wastewater) unless
nvironmental conditions favour the formation of reactive metabolites.
In addition to being relatively low, BCFs in L. minor increase with
ncreasing concentration of oxaliplatin added to the medium ( Table 1 ).5 oreover, when the mode of accumulation is considered, it appears that
ntracellular oxaliplatin rather than extracellular (adsorbed) oxaliplatin
s largely responsible for this increase. An increase in accumulation that
s proportionally greater for the internal fraction does not appear to
e accompanied by a shift in the speciation of oxaliplatin according to
xperimental results reported above ( Fig. 2 ). Moreover, an increase in
oncentration of oxaliplatin relative to [Cl − ] (a constant in the medium)
ould be predicted to result in a reduction in the tendency to form more
eactive metabolites. We note enhanced ion leakage (but not lipid per-
xidation) at the medium and high oxaliplatin concentrations employed
nd suggest that cell membrane damage allows for greater internalisa-
ion of the compound. 
Two end-points were affected by oxaliplatin in the exposures but
ot in a clear dose-dependent manner and only at the high or medium
oncentrations employed (relative growth rate based on frond area
nd ion leakage). Oxaliplatin has been shown to be the least toxic
latinum-based antineoplastic drug towards the freshwater microalga,
hlorella vulgaris , with cisplatin being of greatest environmental concern
 Dehghanpour et al., 2020 ). Regarding L. minor , data arising from expo-
ure to cisplatin for 4 d reported by Supalkova et al. (2008) (including a
0% reduction in growth at 1.5 𝜇g mL − 1 ) suggests that this drug is con-
iderably more toxic than oxaliplatin to the duckweed. More generally,
latinum-based drugs appear to be less toxic to plants than many other
ontaminants, and in particular herbicides, presumably because they
ere specifically developed as alkylating agents for damaging DNA and
estroying cancerous human cells. Thus, such drugs appear to exhibit a
ange of toxicities at low concentrations to various animals, including
quatic fauna ( Gajski et al., 2016 ; Fonseca et al., 2017 ), but there is no
vidence that they inhibit photosynthesis in algal chloroplasts, and cer-
ainly at environmentally relevant concentrations ( Dehghanpour et al.,
020 ). These characteristics also suggest that plants may not be effective
iomonitors for cytotoxic drugs or act as significant vehicles for food-
hain transfer, and certainly at concentrations anticipated in the aquatic
nvironment (on the order of pg L − 1 ; Vyas et al., 2014 ). 
The present study serves as a starting point for understanding both
he bioaccumulation and toxicity of a drug that is increasingly used in
he treatment of cancer ( Wang and Guo, 2013 ). Further studies should























































































ocus on the toxicity of mixtures of such drugs which are combined in
ancer treatment and discharged together into the environment as evi-
ence suggests that mixtures can display synergistic or antagonistic ef-
ects ( Brezov š ek et al., 2014 ). It is also recommended that studies of ox-
liplatin be extended to estuarine conditions where increasing quantities
f chloride and bivalent cations are predicted to facilitate the formation
f more reactive metabolites of the drug. 
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